These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 31528120)

  • 1. Combined high expression of CD47 and CD68 is a novel prognostic factor for breast cancer patients.
    Yuan J; He H; Chen C; Wu J; Rao J; Yan H
    Cancer Cell Int; 2019; 19():238. PubMed ID: 31528120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical Expression of CD47 and CD68 in Breast Carcinoma and Their Prognostic Value.
    Alhanafy S; Hany H; Nasef K; El-Salkh I; Elhawary A
    Asian Pac J Cancer Prev; 2024 Jul; 25(7):2515-2527. PubMed ID: 39068587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD47 and CD68 expression in breast cancer is associated with tumor-infiltrating lymphocytes, blood vessel invasion, detection mode, and prognosis.
    Chen Y; Klingen TA; Aas H; Wik E; Akslen LA
    J Pathol Clin Res; 2023 May; 9(3):151-164. PubMed ID: 36598153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic implications of combined high expression of CD47 and MCT1 in breast cancer: a retrospective study during a 10-year period.
    Sun Y; Liang S; Li T; Peng C; Yang Y; Lin Y; Ma Y; Dong C
    Transl Cancer Res; 2022 Jan; 11(1):29-42. PubMed ID: 35261882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated Analysis of Phagocytic and Immunomodulatory Markers in Cervical Cancer Reveals Constellations of Potential Prognostic Relevance.
    Yordanov A; Damyanova P; Vasileva-Slaveva M; Hasan I; Kostov S; Shivarov V
    Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B7-H3 and CD47 co-expression in gastric cancer is a predictor of poor prognosis and potential targets for future dual-targeting immunotherapy.
    Chen S; Zhan S; Ding S; Zhang Q; Xuan H; Zhang X; Cao L
    J Cancer Res Clin Oncol; 2023 Dec; 149(18):16609-16621. PubMed ID: 37715830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of CD47 and CD68 expression predicts survival in eastern-Asian patients with non-small cell lung cancer.
    Fu F; Zhang Y; Gao Z; Zhao Y; Wen Z; Han H; Li Y; Hu H; Chen H
    J Cancer Res Clin Oncol; 2021 Mar; 147(3):739-747. PubMed ID: 33392661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of CD47 and SIRPα Macrophage Immune-Checkpoint Pathway in Non-Small-Cell Lung Cancer.
    Giatromanolaki A; Mitrakas A; Anestopoulos I; Kontosis A; Koukourakis IM; Pappa A; Panayiotidis MI; Koukourakis MI
    Cancers (Basel); 2022 Apr; 14(7):. PubMed ID: 35406573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD47 expression and tumor-associated immune cells in breast cancer and their correlation with molecular subtypes and prognostic factors.
    Celepli P; Karabulut S; Bigat İ; Celepli S; Hücümenoğlu S
    Pathol Res Pract; 2022 Oct; 238():154107. PubMed ID: 36088827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of tumor-associated macrophages in breast cancer: a meta-analysis of the literature.
    Zhao X; Qu J; Sun Y; Wang J; Liu X; Wang F; Zhang H; Wang W; Ma X; Gao X; Zhang S
    Oncotarget; 2017 May; 8(18):30576-30586. PubMed ID: 28427165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients.
    Medrek C; Pontén F; Jirström K; Leandersson K
    BMC Cancer; 2012 Jul; 12():306. PubMed ID: 22824040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD68, CD163, and matrix metalloproteinase 9 (MMP-9) co-localization in breast tumor microenvironment predicts survival differently in ER-positive and -negative cancers.
    Pelekanou V; Villarroel-Espindola F; Schalper KA; Pusztai L; Rimm DL
    Breast Cancer Res; 2018 Dec; 20(1):154. PubMed ID: 30558648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD68- and CD163-positive tumor infiltrating macrophages in non-metastatic breast cancer: a retrospective study and meta-analysis.
    Ni C; Yang L; Xu Q; Yuan H; Wang W; Xia W; Gong D; Zhang W; Yu K
    J Cancer; 2019; 10(19):4463-4472. PubMed ID: 31528210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The intratumoral distribution influences the prognostic impact of CD68- and CD204-positive macrophages in non-small cell lung cancer.
    Li Z; Maeda D; Yoshida M; Umakoshi M; Nanjo H; Shiraishi K; Saito M; Kohno T; Konno H; Saito H; Minamiya Y; Goto A
    Lung Cancer; 2018 Sep; 123():127-135. PubMed ID: 30089583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-infiltrating CD8+ T cells combined with tumor-associated CD68+ macrophages predict postoperative prognosis and adjuvant chemotherapy benefit in resected gastric cancer.
    Lu J; Xu Y; Wu Y; Huang XY; Xie JW; Wang JB; Lin JX; Li P; Zheng CH; Huang AM; Huang CM
    BMC Cancer; 2019 Sep; 19(1):920. PubMed ID: 31521128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathologic assessment of tumor-associated macrophages and their histologic localization in invasive breast carcinoma.
    Mwafy SE; El-Guindy DM
    J Egypt Natl Canc Inst; 2020 Jan; 32(1):6. PubMed ID: 32372332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and Prognostic Significance of CD47-SIRPA Macrophage Checkpoint Molecules in Colorectal Cancer.
    Sugimura-Nagata A; Koshino A; Inoue S; Matsuo-Nagano A; Komura M; Riku M; Ito H; Inoko A; Murakami H; Ebi M; Ogasawara N; Tsuzuki T; Takahashi S; Kasugai K; Kasai K; Inaguma S
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33799989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD47 (don't eat me signal) expression levels and its relationship with clinicopathologic features in early-stage prostate carcinoma.
    Semiz HS; Küçük Ü; Kısa E; Keskinkılıç M; Süyün DE; Arayıcı ME; Atağ E; Karaoglu A
    Prostate; 2022 Dec; 82(16):1564-1571. PubMed ID: 36031743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting CD47 in Anaplastic Thyroid Carcinoma Enhances Tumor Phagocytosis by Macrophages and Is a Promising Therapeutic Strategy.
    Schürch CM; Roelli MA; Forster S; Wasmer MH; Brühl F; Maire RS; Di Pancrazio S; Ruepp MD; Giger R; Perren A; Schmitt AM; Krebs P; Charles RP; Dettmer MS
    Thyroid; 2019 Jul; 29(7):979-992. PubMed ID: 30938231
    [No Abstract]   [Full Text] [Related]  

  • 20. Tumor-associated Macrophages as Prognostic and Predictive Biomarkers for Postoperative Adjuvant Chemotherapy in Patients with Stage II Colon Cancer.
    Feng Q; Chang W; Mao Y; He G; Zheng P; Tang W; Wei Y; Ren L; Zhu D; Ji M; Tu Y; Qin X; Xu J
    Clin Cancer Res; 2019 Jul; 25(13):3896-3907. PubMed ID: 30988081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.